共 50 条
[41]
Single-dose Tadalafil Reduces Opening Urethral Pressure: A Randomized, Double-blind, Placebo-controlled, Crossover Trial in Healthy Women
[J].
Christoffersen, Thea
;
Riis, Troels
;
Sonne, David P.
;
Klarskov, Niels
.
INTERNATIONAL UROGYNECOLOGY JOURNAL,
2024, 35 (03)
:723-729

论文数: 引用数:
h-index:
机构:

Riis, Troels
论文数: 0 引用数: 0
h-index: 0
机构:
Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Clin Pharmacol, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Clin Pharmacol, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark

Sonne, David P.
论文数: 0 引用数: 0
h-index: 0
机构:
Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Clin Pharmacol, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark
Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Clin Pharmacol, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark

Klarskov, Niels
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
Copenhagen Univ Hosp Herlev & Gentofte, Dept Gynecol & Obstet, Herlev, Denmark Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Clin Pharmacol, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark
[42]
Safety and tolerability of Korean Red Ginseng in healthy adults: a multicenter, double-blind, randomized, placebo-controlled trial
[J].
Song, Sang-Wook
;
Kim, Ha-Na
;
Shim, Jae-Yong
;
Yoo, Byeong-Yeon
;
Kim, Dae-Hyun
;
Lee, Sang-Hyun
;
Park, Joo-Sung
;
Kim, Moon-Jong
;
Yoo, Jun-Hyun
;
Cho, BeLong
;
Kang, Hee-Cheol
;
Kim, Kwang-Min
;
Kim, Sung-Soo
;
Kim, Kyung-Soo
.
JOURNAL OF GINSENG RESEARCH,
2018, 42 (04)
:571-576

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

Shim, Jae-Yong
论文数: 0 引用数: 0
h-index: 0
机构:
Yonsei Univ, Severance Hosp, Coll Med, Dept Family Med, Seoul, South Korea Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea

Yoo, Byeong-Yeon
论文数: 0 引用数: 0
h-index: 0
机构:
Konyang Univ Hosp, Dept Family Med, Daejeon, South Korea Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea

Kim, Dae-Hyun
论文数: 0 引用数: 0
h-index: 0
机构:
Keimyung Univ, Dongsan Hosp, Dept Family Med, Daegu, South Korea Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea

Lee, Sang-Hyun
论文数: 0 引用数: 0
h-index: 0
机构:
Ilsan Hosp, Natl Hlth Insurance Serv, Dept Family Med, Goyang, South Korea Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea

论文数: 引用数:
h-index:
机构:

Kim, Moon-Jong
论文数: 0 引用数: 0
h-index: 0
机构:
CHA Med Univ, CHA Bundang Med Ctr, Dept Family Med, Seongnam, South Korea Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea

Yoo, Jun-Hyun
论文数: 0 引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Family Med, Seoul, South Korea Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea

Cho, BeLong
论文数: 0 引用数: 0
h-index: 0
机构:
Seoul Natl Univ, Coll Med & Hosp, Dept Family Med, Seoul, South Korea Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea

Kang, Hee-Cheol
论文数: 0 引用数: 0
h-index: 0
机构:
Yonsei Univ, Severance Hosp, Coll Med, Dept Family Med, Seoul, South Korea Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea

Kim, Kwang-Min
论文数: 0 引用数: 0
h-index: 0
机构:
Ajou Univ, Sch Med, Ajou Univ Hosp, Dept Family Med, Suwon, South Korea Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:
[43]
Safety, tolerance, and pharmacokinetics of salvianolic acid B in healthy Chinese volunteers: A randomized, double-blind, placebo-controlled phase 1 clinical trial
[J].
Cheng, Junlin
;
Long, Jun
;
Zhang, Jingjing
;
Han, Le
;
Hu, Yunfang
;
Liu, Jianghui
;
Qiu, Runze
;
Zhu, Zhibin
;
Fan, Hongwei
.
FRONTIERS IN PHARMACOLOGY,
2023, 14

Cheng, Junlin
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China

Long, Jun
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Hongqiao Pharmaceut Technol Res Inst Co Lt, Nanjing, Peoples R China Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China

Zhang, Jingjing
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China

Han, Le
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Hongqiao Pharmaceut Technol Res Inst Co Lt, Nanjing, Peoples R China Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China

Hu, Yunfang
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China

Liu, Jianghui
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China

Qiu, Runze
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China

Zhu, Zhibin
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Hongqiao Pharmaceut Technol Res Inst Co Lt, Nanjing, Peoples R China Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China

Fan, Hongwei
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Pharmacol Lab, Nanjing, Peoples R China
[44]
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I Study
[J].
Li, Yinjuan
;
Qi, Lu
;
Bai, Haihong
;
Sun, Chunyun
;
Xu, Shuping
;
Wang, Yu
;
Han, Chunyu
;
Li, Yan
;
Liu, Long
;
Cheng, Xiaoqiang
;
Liu, Ju
;
Lei, Chunpu
;
Tong, Yuanxu
;
Sun, Mingli
;
Yan, Lixin
;
Chen, Weiqiu
;
Liu, Xisheng
;
Liu, Qing
;
Xie, Liangzhi
;
Wang, Xinghe
.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
2021, 65 (11)

Li, Yinjuan
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Qi, Lu
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Bai, Haihong
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Sun, Chunyun
论文数: 0 引用数: 0
h-index: 0
机构:
Sinocelltech Ltd, Beijing, Peoples R China
Beijing Engn Res Ctr Prot & Antibody, Beijing, Peoples R China
Chinese Acad Med Sci & Peking Union Med Coll, Cell Culture Engn Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Xu, Shuping
论文数: 0 引用数: 0
h-index: 0
机构:
Sinocelltech Ltd, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Wang, Yu
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Han, Chunyu
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Li, Yan
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Liu, Long
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Cheng, Xiaoqiang
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Liu, Ju
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Lei, Chunpu
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Tong, Yuanxu
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Sun, Mingli
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Yan, Lixin
论文数: 0 引用数: 0
h-index: 0
机构:
Sinocelltech Ltd, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Chen, Weiqiu
论文数: 0 引用数: 0
h-index: 0
机构:
Sinocelltech Ltd, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Liu, Xisheng
论文数: 0 引用数: 0
h-index: 0
机构:
Sinocelltech Ltd, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Liu, Qing
论文数: 0 引用数: 0
h-index: 0
机构:
Sinocelltech Ltd, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Xie, Liangzhi
论文数: 0 引用数: 0
h-index: 0
机构:
Sinocelltech Ltd, Beijing, Peoples R China
Beijing Engn Res Ctr Prot & Antibody, Beijing, Peoples R China
Chinese Acad Med Sci & Peking Union Med Coll, Cell Culture Engn Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China

Wang, Xinghe
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Dept Phase I Clin Trial Ctr, Beijing, Peoples R China
[45]
Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study
[J].
Li, Shanshan
;
Wu, Xiaojie
;
Li, Nanyang
;
Cao, Guoying
;
Wang, Jingjing
;
Chen, Yuancheng
;
Li, Size
;
He, Jinjie
;
Wu, Jufang
;
Yang, Haijing
;
Lin, Ke
;
Qiu, Chao
;
Liu, Angela
;
Zhou, He
;
Adrian, Francisco
;
Schweizer, Liang
;
Zhang, Wenhong
;
Gu, Jingwen
;
Zhang, Jing
.
FRONTIERS IN PHARMACOLOGY,
2023, 14

Li, Shanshan
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Wu, Xiaojie
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Phase Clin Res Ctr 1, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Li, Nanyang
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Phase Clin Res Ctr 1, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Cao, Guoying
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Phase Clin Res Ctr 1, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Wang, Jingjing
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Phase Clin Res Ctr 1, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Chen, Yuancheng
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Phase Clin Res Ctr 1, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Li, Size
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Phase Clin Res Ctr 1, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

He, Jinjie
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Phase Clin Res Ctr 1, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Wu, Jufang
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Phase Clin Res Ctr 1, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Yang, Haijing
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Phase Clin Res Ctr 1, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Lin, Ke
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Qiu, Chao
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Liu, Angela
论文数: 0 引用数: 0
h-index: 0
机构:
HiFiBiO Hang Zhou Ltd, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Zhou, He
论文数: 0 引用数: 0
h-index: 0
机构:
HiFiBiO Hang Zhou Ltd, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Adrian, Francisco
论文数: 0 引用数: 0
h-index: 0
机构:
HiFiBiO Hang Zhou Ltd, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Schweizer, Liang
论文数: 0 引用数: 0
h-index: 0
机构:
HiFiBiO Hang Zhou Ltd, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Zhang, Wenhong
论文数: 0 引用数: 0
h-index: 0
机构:
HiFiBiO Hang Zhou Ltd, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Gu, Jingwen
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China

Zhang, Jing
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Huashan Hosp, Phase Clin Res Ctr 1, Shanghai, Peoples R China
Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai, Peoples R China Fudan Univ, Huashan Hosp, Huashan Worldwide Med Ctr, Shanghai, Peoples R China
[46]
A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects
[J].
Abbas, Richat
;
Hug, Bruce A.
;
Leister, Cathie
;
El Gaaloul, Myriam
;
Chalon, Stephan
;
Sonnichsen, Daryl
.
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
2012, 69 (01)
:221-227

Abbas, Richat
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, Dept Clin Pharmacol, Collegeville, PA 19426 USA Pfizer Inc, Dept Clin Pharmacol, Collegeville, PA 19426 USA

Hug, Bruce A.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, Dept Clin Pharmacol, Collegeville, PA 19426 USA Pfizer Inc, Dept Clin Pharmacol, Collegeville, PA 19426 USA

Leister, Cathie
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, Dept Clin Pharmacol, Collegeville, PA 19426 USA Pfizer Inc, Dept Clin Pharmacol, Collegeville, PA 19426 USA

El Gaaloul, Myriam
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Global Res & Dev, Dept Clin Pharmacol, Paris, France Pfizer Inc, Dept Clin Pharmacol, Collegeville, PA 19426 USA

Chalon, Stephan
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Global Res & Dev, Dept Clin Pharmacol, Paris, France Pfizer Inc, Dept Clin Pharmacol, Collegeville, PA 19426 USA

Sonnichsen, Daryl
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, Dept Clin Pharmacol, Collegeville, PA 19426 USA Pfizer Inc, Dept Clin Pharmacol, Collegeville, PA 19426 USA
[47]
A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects
[J].
Richat Abbas
;
Bruce A. Hug
;
Cathie Leister
;
Myriam El Gaaloul
;
Stephan Chalon
;
Daryl Sonnichsen
.
Cancer Chemotherapy and Pharmacology,
2012, 69
:221-227

Richat Abbas
论文数: 0 引用数: 0
h-index: 0
机构: Pfizer Inc,Department of Clinical Pharmacology

Bruce A. Hug
论文数: 0 引用数: 0
h-index: 0
机构: Pfizer Inc,Department of Clinical Pharmacology

Cathie Leister
论文数: 0 引用数: 0
h-index: 0
机构: Pfizer Inc,Department of Clinical Pharmacology

Myriam El Gaaloul
论文数: 0 引用数: 0
h-index: 0
机构: Pfizer Inc,Department of Clinical Pharmacology

Stephan Chalon
论文数: 0 引用数: 0
h-index: 0
机构: Pfizer Inc,Department of Clinical Pharmacology

Daryl Sonnichsen
论文数: 0 引用数: 0
h-index: 0
机构: Pfizer Inc,Department of Clinical Pharmacology
[48]
A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers
[J].
Green, Francis H. Y.
;
Leigh, Richard
;
Fadayomi, Morenike
;
Lalli, Gurkeet
;
Chiu, Andrea
;
Shrestha, Grishma
;
ElShahat, Sharif G.
;
Nelson, David Evan
;
El Mays, Tamer Y.
;
Pieron, Cora A.
;
Dennis, John H.
.
TRIALS,
2016, 17

Green, Francis H. Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada

Leigh, Richard
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calgary, Dept Med, Calgary, AB, Canada Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada

Fadayomi, Morenike
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada

Lalli, Gurkeet
论文数: 0 引用数: 0
h-index: 0
机构:
SolAeroMed Inc, Calgary, AB, Canada Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada

Chiu, Andrea
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada
SolAeroMed Inc, Calgary, AB, Canada Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada

Shrestha, Grishma
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada

ElShahat, Sharif G.
论文数: 0 引用数: 0
h-index: 0
机构:
SolAeroMed Inc, Calgary, AB, Canada Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada

Nelson, David Evan
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada

El Mays, Tamer Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada

Pieron, Cora A.
论文数: 0 引用数: 0
h-index: 0
机构:
SolAeroMed Inc, Calgary, AB, Canada Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada

Dennis, John H.
论文数: 0 引用数: 0
h-index: 0
机构:
SolAeroMed Inc, Calgary, AB, Canada Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada
[49]
A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers
[J].
Francis H. Y. Green
;
Richard Leigh
;
Morenike Fadayomi
;
Gurkeet Lalli
;
Andrea Chiu
;
Grishma Shrestha
;
Sharif G. ElShahat
;
David Evan Nelson
;
Tamer Y. El Mays
;
Cora A. Pieron
;
John H. Dennis
.
Trials,
17

Francis H. Y. Green
论文数: 0 引用数: 0
h-index: 0
机构: University of Calgary,Department of Pathology & Laboratory Medicine

Richard Leigh
论文数: 0 引用数: 0
h-index: 0
机构: University of Calgary,Department of Pathology & Laboratory Medicine

Morenike Fadayomi
论文数: 0 引用数: 0
h-index: 0
机构: University of Calgary,Department of Pathology & Laboratory Medicine

Gurkeet Lalli
论文数: 0 引用数: 0
h-index: 0
机构: University of Calgary,Department of Pathology & Laboratory Medicine

Andrea Chiu
论文数: 0 引用数: 0
h-index: 0
机构: University of Calgary,Department of Pathology & Laboratory Medicine

Grishma Shrestha
论文数: 0 引用数: 0
h-index: 0
机构: University of Calgary,Department of Pathology & Laboratory Medicine

Sharif G. ElShahat
论文数: 0 引用数: 0
h-index: 0
机构: University of Calgary,Department of Pathology & Laboratory Medicine

David Evan Nelson
论文数: 0 引用数: 0
h-index: 0
机构: University of Calgary,Department of Pathology & Laboratory Medicine

Tamer Y. El Mays
论文数: 0 引用数: 0
h-index: 0
机构: University of Calgary,Department of Pathology & Laboratory Medicine

Cora A. Pieron
论文数: 0 引用数: 0
h-index: 0
机构: University of Calgary,Department of Pathology & Laboratory Medicine

John H. Dennis
论文数: 0 引用数: 0
h-index: 0
机构: University of Calgary,Department of Pathology & Laboratory Medicine
[50]
A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers
[J].
Wang, Xinghe
;
Liu, Long
;
Qi, Lu
;
Lei, Chunpu
;
Li, Pu
;
Wang, Yu
;
Liu, Chen
;
Bai, Haihong
;
Han, Chengquan
;
Sun, Yinjian
;
Liu, Jincan
.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,
2021, 25 (17)
:8222-8228

Wang, Xinghe
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China

Liu, Long
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China

Qi, Lu
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China

Lei, Chunpu
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China

Li, Pu
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China

Wang, Yu
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China

Liu, Chen
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China

Bai, Haihong
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China

Han, Chengquan
论文数: 0 引用数: 0
h-index: 0
机构:
Beijing Northland Biotech Co Ltd, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China

Sun, Yinjian
论文数: 0 引用数: 0
h-index: 0
机构:
Beijing Northland Biotech Co Ltd, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China

Liu, Jincan
论文数: 0 引用数: 0
h-index: 0
机构:
Beijing Northland Biotech Co Ltd, Beijing, Peoples R China Capital Med Univ, Beijing Shijitan Hosp, Phase I Clin Trial Ctr, Beijing, Peoples R China